ARCHIVES

Telatinib Demonstrates Positive Results in First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

“Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel

February 22, 1974

Nine New Grants Awarded In The NCI “Director’s Challenge”.

October 13, 2000

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008